(Q50799197)

19 March 2018

title

Group I metabotropic glutamate receptor antagonists alter select behaviors in a mouse model for fragile X syndrome. (English)

1 reference

19 March 2018

6-methyl-2-(phenylethynyl)pyridine

main subject

1 reference

ChEBI release 2020-05-28

1 reference

Alexia M Thomas

1

1 reference

19 March 2018

Nghiem Bui

2

1 reference

19 March 2018

Jennifer R Perkins

3

1 reference

19 March 2018

Lisa A Yuva-Paylor

4

1 reference

19 March 2018

Richard Paylor

5

1 reference

19 March 2018

publication date

10 June 2011

1 reference

19 March 2018

published in

Psychopharmacology

1 reference

19 March 2018

volume

219

1 reference

19 March 2018

issue

1

1 reference

19 March 2018

page(s)

47-58

1 reference

19 March 2018

https://scigraph.springernature.com/pub.10.1007/s00213-011-2375-4

exact match

0 references

cites work

Reduced hippocampal long-term potentiation and context-specific deficit in associative learning in mGluR1 mutant mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

The mGluR theory of fragile X mental retardation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Knockout mouse model for Fxr2: a model for mental retardation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Interactions of the mGluR5 gene with breeding and maternal factors on startle and prepulse inhibition in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Major tranquillizers can be distinguished from minor tranquillizers on the basis of effects on marble burying and swim-induced grooming in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Fragile X mice develop sensory hyperreactivity to auditory stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Metabotropic glutamate receptors in the basal ganglia motor circuit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Motor deficit and impairment of synaptic plasticity in mice lacking mGluR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Fragile X syndrome: from molecular genetics to therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Regulation of metabotropic glutamate receptor signaling, desensitization and endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Correction of fragile X syndrome in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Mechanism-based approaches to treating fragile X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Blockade of mGluR1 receptor results in analgesia and disruption of motor and cognitive performances: effects of A-841720, a novel non-competitive mGluR1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Advances in the treatment of fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Compulsive, self-injurious, and autistic behavior in children and adolescents with fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

The mGluR5 antagonist MPEP, but not the mGluR2/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Pharmacological effects of metabotropic glutamate receptor ligands on prepulse inhibition in DBA/2J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Characterization of the selective mGluR1 antagonist, JNJ16259685, in rodent models of movement and coordination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Sustained activation of metabotropic glutamate receptor 5 and protein tyrosine phosphatases mediate the expression of (S)-3,5-dihydroxyphenylglycine-induced long-term depression in the hippocampal CA1 region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Rap1-induced p38 mitogen-activated protein kinase activation facilitates AMPA receptor trafficking via the GDI.Rab5 complex. Potential role in (S)-3,5-dihydroxyphenylglycene-induced long term depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Altered synaptic plasticity in a mouse model of fragile X mental retardation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

JNJ16259685, a highly potent, selective and systemically active mGlu1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Alterations in the auditory startle response in Fmr1 targeted mutant mouse models of fragile X syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Reversal of sensorimotor gating abnormalities in Fmr1 knockout mice carrying a human Fmr1 transgene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

(Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

mGluR5, but not mGluR1, antagonist modifies MK-801-induced locomotor activity and deficit of prepulse inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

The metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) blocks fear conditioning in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Modifying behavioral phenotypes in Fmr1KO mice: genetic background differences reveal autistic-like responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

The fragile X mental retardation protein is required for type-I metabotropic glutamate receptor-dependent translation of PSD-95

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Contribution of mGluR and Fmr1 functional pathways to neurite morphogenesis, craniofacial development and fragile X syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Differential roles for group 1 mGluR subtypes in induction and expression of chemically induced hippocampal long-term depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function. I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Metabotropic glutamate subtype 5 receptors modulate fear-conditioning induced enhancement of prepulse inhibition in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2375-4

Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP

21 January 2018

1 reference

12 December 2020

Chemical induction of mGluR5- and protein synthesis--dependent long-term depression in hippocampal area CA1.

1 reference

12 December 2020

Deficient cerebellar long-term depression and impaired motor learning in mGluR1 mutant mice

1 reference

12 December 2020

Modulation of presynaptic calcium transients by metabotropic glutamate receptor activation: a differential role in acute depression of synaptic transmission and long-term depression.

1 reference

12 December 2020

Effects of the prototypical mGlu(5) receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine on rotarod, locomotor activity and rotational responses in unilateral 6-OHDA-lesioned rats

1 reference

12 December 2020

Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents.

1 reference

12 December 2020

10.1007/S00213-011-2375-4

Identifiers

DOI

1 reference

19 March 2018

1 reference

19 March 2018